Certified by Founder
Lodge
Encellin
start up
United States
- Mountain View
- 14/12/2023
- Unknown
- $9,900,000
Encellin is focused on advancing next generation therapies, starting with endocrine disorders.
We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases.
- Industry Biotechnology Research
- Website https://www.encellin.com/
- LinkedIn https://www.linkedin.com/company/encellin/about/
Prefix Maintenance | $7,500,000 | (Apr 15, 2026)
nEye.ai | $80,000,000 | (Apr 15, 2026)
Sygaldry Technologies | $105,000,000 | (Apr 15, 2026)
Smartwage Società Benefit | $2,000,000 | (Apr 15, 2026)
Convelio | Undisclosed Amount | (Apr 15, 2026)
Neato® | $25,000,000 | (Apr 15, 2026)
Synera | $40,000,000 | (Apr 15, 2026)
Turion Space | $75,000,000 | (Apr 15, 2026)
Remission Medical | Undisclosed Amount | (Apr 14, 2026)
Slate Auto | $650,000,000 | (Apr 14, 2026)
Qoro | $750,000 | (Apr 14, 2026)